辉瑞Investor-Overview-at-2025-JPM-vFINAL

1Pfizer Investor OverviewAt 2025 J.P. Morgan Healthcare ConferenceJanuary 20252•Thesematerials will include forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We include forward-looking statements about, among other topics, our anticipated operating and financial performance, including financial guidance and projections; changes to Pfizer's commercial organization; reorganizations; business plans, strategy, goals and prospects;expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, includingdemand, market size and utilization rates and growth, performance, timing of exclusivity and p